Professor Christof von Kalle has been head of the Department of Translational Oncology at the NCT and the German Cancer Research Center (DKFZ) since July 2005 as well as managing director of the National Center for Tumor Diseases (NCT) Heidelberg from July 2005 to March 2018. As a physician scientist with a clinical background in haematology/oncology and more than 200 high-impact publications, Prof. von Kalle is an internationally renowned leading scientist in stem-cell research, mutation analysis, and gene transfer.
